Indian Government Rejects WHO Definition Of Counterfeit Drugs; Stresses Need For Harmonization Among Member States
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Indian government may have succeeded in blocking a move to redefine "counterfeit drugs" by the International Medical Products Anti-Counterfeiting Taskforce - an arm of the World Health Organization. In its definition, IMPACT defined a medical product as counterfeit "when there is a false representation in relation to its identity, history or source.